A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

RNA viruses pose significant challenges to public health due to their high mutation rates and diverse mechanisms of infection which allow them to rapidly adapt to new hosts and evade therapeutic ...

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, 10-day treatment course, ...

Illinois health officials receive flu and COVID-19 vaccinations, emphasizing the importance of immunization before the ...

On Tuesday, his first morning back in the White House, the president took to Twitter to compare Covid-19 to the flu ...

Millions of people could skip the GP queue this winter and get the advice and medication they need amid warnings of a ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Chatham-Kent health agencies urge the public to take advantage of the flu and COVID-19 vaccines and RSV (respiratory ...

Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution (16 vs 19 days; HR, 1.20) through 28 days and cut the number of ...

Aristotle Capital Boston, LLC, an investment advisor, released its “Small/Mid Cap Equity Strategy” third quarter 2024 investor letter.